Saltar al contenido
Merck
  • QSAR study and conformational analysis of 4-arylthiazolylhydrazones derived from 1-indanones with anti-Trypanosoma cruzi activity.

QSAR study and conformational analysis of 4-arylthiazolylhydrazones derived from 1-indanones with anti-Trypanosoma cruzi activity.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences (2015-07-27)
Guido J Noguera, Lucas E Fabian, Elisa Lombardo, Liliana Finkielsztein
RESUMEN

A set of 4-arylthiazolylhydrazones derived from 1-indanones (TZHs) previously synthesized and assayed against Trypanosoma cruzi, the causative agent of Chagas disease, were explored in terms of conformational analysis. We found that TZHs can adopt four minimum energy conformations: cis (A, B and C) and trans. The possible bioactive conformation was selected by a 3D-QSAR model. Different molecular parameters were calculated to produce QSAR second-generation models. These QSAR results are discussed in conjunction with conformational analysis from molecular modeling studies. The main factor to determine the activity of the compounds was the partial charge at the N(3) atom (qN3). The predictive ability of the QSAR equations proposed was experimentally validated. The QSAR models developed in this study will be helpful to design novel potent TZHs.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Bromuro de potasio, BioUltra, ≥99.5% (AT)
Sigma-Aldrich
2-Bromo-4′-methoxyacetophenone, 97%
Sigma-Aldrich
Bromuro de potasio, anhydrous, powder, 99.999% trace metals basis
Sigma-Aldrich
Bromuro de potasio, anhydrous, powder, 99.95% trace metals basis
Sigma-Aldrich
2-Bromo-4′-nitroacetophenone, 95%
Sigma-Aldrich
Bromuro de potasio, BioXtra, ≥99.0%
Sigma-Aldrich
Bromuro de potasio, JIS special grade, 99.0-100.2%